ask="39.85"
ask_size="200"
average_daily_volume="1073850"
bid="37.71"
bid_size="200"
book_value="4.05"
change="-2.08"
change_from_200_day_moving_average="-6.97"
change_from_50_day_moving_average="-1.71"
change_from_52_week_high="-14.98"
change_From_52_week_low="8.92"
change_in_percent="-4.92%"
close="40.17"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.45"
ebitda="-134.59M"
eps_estimate_current_year="-1.68"
eps_estimate_next_quarter="-0.41"
eps_estimate_next_year="-1.76"
ex_dividend_date="N/A"
float_shares="85807000"
high="42.81"
high_52_weeks="55.15"
last_trade_date="1/17/2017"
last_trade_price="40.17"
last_trade_size="61987"
last_trade_time="4:00pm"
low="39.87"
low_52_weeks="31.25"
market_capitalization="3.49B"
moving_average_200_day="47.14"
moving_average_50_day="41.88"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="68.00"
open="41.94"
pe_ratio="N/A"
peg_ratio="0.69"
percent_change_from_200_day_moving_average="-14.79%"
percent_change_from_50_day_moving_average="-4.09%"
percent_change_from_52_week_high="-27.16%"
percent_change_from_52_week_low="+28.54%"
previous_close="42.25"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="10.44"
price_per_sales="244.69"
revenue="15.00M"
shares_outstanding="86871000"
short_ratio="3.55"
stock_exchange="NMS"
symbol="NBIX"
volume="1784687"
weeks_range_52="31.25 - 55.15"
